|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 10:00 Today
- Deutsche Bank falls -6.7%
- 09:47 Today
- Deutsche Bank falls -6.5%
- 03/22/23
- Deutsche Bank raises prime lending rate to 8.00% from 7.75%, effective March 23
- 02/02/23
- Deutsche Bank reaffirms financial targets for 2025
- 03/06/23
- Altria Group to acquire NJOY Holdings for $2.75B in cash
- 03/03/23
- Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights
- 01/24/23
- Altria Group trading resumes
- 01/24/23
- Altria Group trading halted, volatility trading pause
- 02/03/23
- Clorox rises 9.6%
- 02/02/23
- Clorox sees FX headwinds a 2-point reduction to FY23 sales
- 02/02/23
- Clorox CEO says 'actions we are taking to rebuild margin are working'
- 02/02/23
- Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago
- 03/23/23
- Scholastic falls 11% to $36.90 after lowering FY23 guidance
- 03/23/23
- Scholastic board authorizes additional $50M for share repurchases
- 02/22/23
- Scholastic announces strategic partnership with SoapBox Labs
- 12/15/22
- Scholastic raises share repurchase authorization to $75M
- 03/13/23
- Joann announces $100M FILO credit facility
- 10/10/22
- Joann, Sutton Foster team up for World Mental Health Day
- 03/23/23
- Cathie Wood's ARK Investment bought 269K shares of Coinbase today
- 03/22/23
- Coinbase says 'we are confident in the legality of our assets and services'
- 03/22/23
- Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC
- 03/22/23
- Coinbase receives Wells Notice from SEC
- 06:43 Today
- Block continues selloff, shares down 4% to $59.31
- 03/23/23
- Cathie Wood's ARK Investment bought 338K shares of Block today
- 03/23/23
- Block exploring legal action against Hindenburg after 'misleading' report
- 03/23/23
- Block calls Hindenburg report 'factually inaccurate and misleading'
- 03/17/23
- XPeng rises 10.8%
- 03/17/23
- XPeng announces 5,218 vehicles delivered in January
- 03/10/23
- XPeng laiuches P7i sports sedan in China
- 03/01/23
- XPeng delivers 6,010 Smart EVs in February
- $820.34 /
+17.72 (+2.21%) - 03/23/23
- Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
- 03/22/23
- Regeneron announces FDA approval of Evkeeza for young children
- 03/21/23
- Regeneron, Sanofi announce EC approval of Dupixent
- 03/19/23
- Regeneron, Sanofi present results from Dupixent clinical trial
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/19/23
- Credit Suisse says UBS confident staff employment will be continued
- 02/13/23
- ReNew Energy to rebrand as ReNew
- 12/16/22
- ReNew Energy Global signs 150 MW agreement with Microsoft
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/16/23
- First Republic confirms it will receive deposits totaling $30B from banks
- 03/23/23
- Stifel Financial announces significant expansion of venture banking business
- 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/22/23
- Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate
- 03/20/23
- WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank
- $205.99 /
+1.695 (+0.83%) - 03/21/23
- Nvidia announces availability of new products featuring H100 Tensor Core GPU
- 03/15/23
- Facebook Ireland violated law over data use, Amsterdam court ruled
- 03/15/23
- Oportun Financial expands executive team with key new hires
- 03/14/23
- Meta targeting summer to complete analysis from hybrid work year of learning
- 03/02/23
- Yield10 Bioscience, American Airlines sign MOU to form collaboration
- 02/23/23
- American Airlines chairman Doug Parker to retire, Greg Smith to succeed
- 02/08/23
- American Airlines announces proposed offering of senior secured notes
- 01/26/23
- American Airlines sees delivery of 17 737 Max 8s in 2023
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/16/23
- First Republic confirms it will receive deposits totaling $30B from banks
- 03/16/23
- Fed, Treasury say banks' deposits in First Republic show system's 'resilience'
- 03/16/23
- Group of banks confirm plan to make deposits totaling $30B in First Republic
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/23/23
- Nano Dimension releases video on products, materials, technologies
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/21/23
- Nano Dimension responds to Murchinson claims about shareholder meeting results
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- Nano Dimension CEO provides rationale for acquisition of Stratasys
- 08:19 Today
- CMA 'narrows scope of concerns' in Microsoft-Activision review
- 03/15/23
- Microsoft signs 10-year Xbox PC game partnership with Ubitus
- 03/14/23
- Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass
- 03/10/23
- Sony says 'Hogwarts Legacy' most downloaded PS5 game in February
- 08:19 Today
- CMA 'narrows scope of concerns' in Microsoft-Activision review
- 03/22/23
- Microsoft, CarbonCapture reach carbon removal credits agreement
- 03/22/23
- Syneos Health and KX team on predictive analytics, AI and ML
- 03/21/23
- Nvidia says Nvidia Omniverse Cloud now available to select enterprises
- 14:44 Today
- Pharming up 22% after resuming trading following announcement of FDA approval
- 14:31 Today
- Pharming up 7% after FDA approves Joenja for APDS
- 14:31 Today
- Pharming announces FDA approval of Joenja
- 02/21/23
- Pharming announces first patient enrolled in leniolisib trial
AMPX Amprius Technologies - 12:00 Today
- Amprius Technologies falls -8.0%
- 09:47 Today
- Amprius Technologies rises 6.8%
- 03/23/23
- Amprius Technologies says will be 'limited by manufacturing capacity'
- 03/06/23
- Amprius Technologies selects Colorado for new facility
- 10:00 Today
- Farfetch falls -8.1%
- 02/24/23
- Farfetch rises 13.0%
- 02/23/23
- Farfetch CFO Jordan to step down by end of 2023
- 01/18/23
- Farfetch announces changes to leadership team
IMPL Impel Pharmaceuticals - 08:21 Today
- Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023
- 08:20 Today
- Impel Pharmaceuticals expects cash to fund operations into 3Q23
- 02/22/23
- Impel Pharmaceuticals announces strategic reprioritization, departure of CMO
- 09/28/22
- Impel Pharmaceuticals Inc trading resumes
- 15:14 Today
- Stifel Financial co-president Zemlyak buys 20,000 common shares
- 03/23/23
- Stifel Financial announces significant expansion of venture banking business
- 03/01/23
- Stifel Financial closes acquisition of Torreya partners
- 02/16/23
- Stifel Financial announces launch of an ASPG, new hires
- 07:04 Today
- Oncorus expects cash to fund expenditures into early 2024
- 03/10/23
- Oncorus informs investors of holdings with SVB Financial
- 01/04/23
- Oncorus announces research collaboration with Daewoong Pharmaceutical
- 11/30/22
- Oncorus announces reprioritization of lead product candidate ONCR-021
- 03/16/23
- Leap Therapeutics provides update on BeiGene option agreement for DKN-01
- 01/17/23
- Leap Therapeutics acquires Flame Biosciences
- 11/07/22
- Leap Therapeutics' DKN-01 demonstrates preclinical tumor regression in study
- 10/17/22
- Leap Therapeutics enrolls first patient in study of colorectal cancer candidate
- 07:02 Today
- Humacyte expects cash to fund operations through 2024
- 01/24/23
- Humacyte announces publication of 6-year outcomes in Phase 2 study of HAV
- 12/13/22
- Humacyte hosts KOL webinar on vascular trauma
- 11/10/22
- Humacyte expects cash to fund operations through 2024
- 02/10/23 BofA
- Deutsche Bank downgraded to Underperform from Neutral at BofA
- 02/08/23 UBS
- Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS
- 02/03/23 Credit Suisse
- Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse
- 01/13/23 Barclays
- Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays
- 11/10/22 UBS
- UBS downgrades Altria to Sell on consumer trade down risk
- 11/10/22 UBS
- Altria Group downgraded to Sell from Neutral at UBS
- 11/02/22 Morgan Stanley
- Philip Morris price target raised to $109 from $102 at Morgan Stanley
- 10/28/22 Stifel
- Altria JV news trumps 'rare' EPS miss, says Stifel
- 03/20/23 Deutsche Bank
- Clorox price target lowered to $147 from $152 at Deutsche Bank
- 02/16/23 Citi
- Citi launches beverage, personal space with six buys, two sells
- 02/16/23 Citi
- Clorox initiated with a Neutral at Citi
- 02/06/23 Barclays
- Clorox price target lowered to $108 from $110 at Barclays
- 08:12 Today Loop Capital
- Joann price target lowered to $2 from $4 at Loop Capital
- 12/14/22 Barclays
- Joann price target lowered to $3 from $5 at Barclays
- 12/13/22 Loop Capital
- Joann price target lowered to $4 from $7 at Loop Capital
- 09/02/22 Wells Fargo
- Joann price target lowered to $4 from $5 at Wells Fargo
- 07:39 Today Compass Point
- Coinbase Wells notice fight will take 'years to resolve,' says Compass Point
- 05:36 Today TD Cowen
- Coinbase downgraded to Underperform from Market Perform at TD Cowen
- 03/23/23 BofA
- SEC action to weigh on Coinbase shares, says BofA
- 03/23/23 Jefferies
- Coinbase Wells notice likely precursor to enforcement action, says Jefferies
- 07:49 Today Oppenheimer
- Oppenheimer remains on the sidelines for Block after short report
- 06:57 Today BofA
- Block shares 'overreacting' to short seller report, says BofA
- 06:28 Today Citi
- Block short seller response likely not enough, says Citi
- 05:32 Today Atlantic Equities
- Atlantic Equities downgrades Block pending more clarity on short report
- 08:35 Today Bernstein
- XPeng downgraded to Market Perform from Outperform at Bernstein
- 08:26 Today Bernstein
- XPeng downgraded to Market Perform from Outperform at Bernstein
- 03/20/23 Morgan Stanley
- XPeng price target raised to $12.50 from $12 at Morgan Stanley
- 03/20/23 Morgan Stanley
- Li Auto price target raised to $30 from $23 at Morgan Stanley
- $820.34 /
+17.72 (+2.21%) - 09:04 Today BMO Capital
- Regeneron price target raised to $1,040 from $1,025 at BMO Capital
- 06:36 Today Wells Fargo
- Regeneron price target raised to $915 from $860 at Wells Fargo
- 06:31 Today Baird
- Regeneron price target raised to $800 from $756 at Baird
- 06:01 Today Barclays
- Regeneron price target raised to $915 from $815 at Barclays
- 04:35 Today Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/20/23 Keefe Bruyette
- UBS downgraded to Underperform from Market Perform at Keefe Bruyette
- 07:48 Today RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 07:11 Today Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/23/23 Raymond James
- Block short report doesn't include 'bombshell,' says Raymond James
- 03/22/23 BofA
- Regional bank distress gives CME Group a new growth opportunity, says BofA
- 03/20/23 Benchmark
- Aspen Aerogels upgraded to Buy from Hold at Benchmark
- $205.99 /
+1.695 (+0.83%) - 07:46 Today JPMorgan
- Meta Platforms price target raised to $270 from $225 at JPMorgan
- 06:04 Today Barclays
- Meta Platforms price target raised to $270 from $260 at Barclays
- 03/22/23 KeyBanc
- Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc
- 03/21/23 Morgan Stanley
- Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/17/23 Wolfe Research
- American Airlines upgraded to Peer Perform from Underperform at Wolfe Research
- 03/17/23 Wolfe Research
- American Airlines upgraded to Peer Perform from Underperform at Wolfe Research
- 03/10/23 Barclays
- American Airlines price target raised to $15 from $14 at Barclays
- 03/07/23 Evercore ISI
- Delta Air Lines upgraded to Outperform from In Line at Evercore ISI
- 07:49 Today RBC Capital
- Bank of America price target lowered to $34 from $40 at RBC Capital
- 03/08/23 Odeon Capital
- Bank of America downgraded to Hold from Buy at Odeon Capital
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 02/08/23 Keefe Bruyette
- Bank of America downgraded to Underperform at Keefe Bruyette
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 02/16/23 Deutsche Bank
- Deutsche upgrades Activision to Buy, says best risk/reward in gaming
- 02/16/23 Deutsche Bank
- Activision Blizzard upgraded to Buy from Hold at Deutsche Bank
- 02/10/23 Roth MKM
- Activision Blizzard price target lowered to $88 from $95 at Roth MKM
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 03/20/23 Stifel
- Alphabet resumed with a Buy at Stifel
- 03/20/23 Evercore ISI
- Microsoft price target raised to $295 from $280 at Evercore ISI
- 03/17/23 Mizuho
- Microsoft price target raised to $315 from $300 at Mizuho
AMPX Amprius Technologies - 12/02/22 B. Riley
- B. Riley starts 'early battery winner' Amprius with Buy, $14 target
- 12/01/22 B. Riley
- Amprius Technologies initiated with a Buy at B. Riley
- 10/27/22 EF Hutton
- Amprius Technologies initiated with a Buy at EF Hutton
- 10/13/22 Oppenheimer
- Amprius Technologies initiated with an Outperform at Oppenheimer
- 06:18 Today Citi
- Farfetch price target lowered to $4 from $6 at Citi
- 04:48 Today JMP Securities
- Farfetch initiated with a Market Perform at JMP Securities
- 01/30/23 KeyBanc
- KeyBanc keeps Overweight on Farfetch, lowers price target to $11
- 12/15/22 Oppenheimer
- Farfetch price target lowered to $7 from $14 at Oppenheimer
IMPL Impel Pharmaceuticals - 11/15/22 Wedbush
- Wedbush downgrades Impel Pharmaceuticals to Neutral, lowers price target to $5
- 11/15/22 Wedbush
- Impel Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
- 08/24/22 JonesTrading
- Impel Pharmaceuticals initiated with a Buy at JonesTrading
- 01/12/23 Citi
- Stifel Financial price target raised to $65 from $60 at Citi
- 01/10/23 JMP Securities
- Stifel Financial price target lowered to $95 from $98 at JMP Securities
- 11/22/22 UBS
- Stifel Financial initiated with a Neutral at UBS
- 10/12/22 Citi
- Citi starts exchanges and brokers with CME, MarketAxess among top picks
- 12/06/22 H.C. Wainwright
- Oncorus downgraded to Neutral from Buy at H.C. Wainwright
- 11/30/22 Chardan
- Oncorus downgraded to Neutral from Buy at Chardan
- 11/30/22 Piper Sandler
- Piper downgrades Oncorus with plug pulled on lead program
- 11/30/22 Piper Sandler
- Oncorus downgraded to Neutral from Overweight at Piper Sandler
- 03/17/23 Piper Sandler
- Leap Therapeutics news 'disappointing at first glance,' says Piper Sandler
- 03/17/23 Mizuho
- Leap Therapeutics price target lowered to $2 from $3 at Mizuho
- 01/27/23 Mizuho
- Leap Therapeutics price target lowered to $3 from $6 at Mizuho
- 01/17/23 Piper Sandler
- Leap Therapeutics price target lowered to $3 from $4 at Piper Sandler
- 03/12/23 BTIG
- BTIG finds medical technology stocks with exposure with SVB
- 12/19/22 Cowen
- Humacyte price target lowered to $5 from $8 at Cowen
- 11/10/22 Piper Sandler
- Humacyte price target lowered to $2.75 from $3.50 at Piper Sandler
- 10/12/22 Piper Sandler
- CMS proposal a positive for Med Tech sector, says Piper Sandler
- 02/02/23
- Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year
- 10/26/22
- Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B
- 10/26/22
- Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B
- 03/23/23
- Altria Group affirms FY23 EPS view of $4.98-$5.13, consensus $5.06
- 02/01/23
- Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05
- 02/01/23
- Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17
- 01/31/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22
- 02/02/23
- Clorox reports Q2 adjusted EPS 98c, consensus 65c
- 02/02/23
- Notable companies reporting after market close
- 11/01/22
- Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07
- 03/23/23
- Scholastic cuts FY23 revenue growth view to about 4% from 8%-10%
- 03/23/23
- Scholastic reports Q3 EPS (57c) vs. (44c) last year
- 12/15/22
- Scholastic backs FY23 revenue growth 8%-10%
- 12/15/22
- Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago
- 03/23/23
- Joann reports Q4 EPS 7c, may not compare to consensus 70c
- 12/12/22
- Joann reports Q3 adjusted EPS 6c, consensus 23c
- 02/21/23
- Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y
- 02/21/23
- Notable companies reporting after market close
- 01/10/23
- Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail'
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 02/23/23
- Block reports Q4 EPS 22c, consensus 30c
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Block reports Q3 adjusted EPS 42c, consensus 23c
- 11/03/22
- Notable companies reporting after market close
- 03/17/23
- XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M
- 03/17/23
- XPeng reports Q4 adjusted EPS (37c), consensus (36c)
- 11/30/22
- XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B
- 11/30/22
- XPeng reports Q3 EPS (36c), consensus (36c)
- $820.34 /
+17.72 (+2.21%) - 02/03/23
- Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 01/09/23
- Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- $205.99 /
+1.695 (+0.83%) - 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 01/26/23
- American Airlines sees Q1 adjusted EPS approx. breakeven, consensus 1c
- 01/26/23
- American Airlines sees 2023 adjusted EPS $2.50-$3.50, consensus $1.77
- 01/26/23
- American Airlines reports Q4 EPS ex-items $1.17, consensus $1.14
- 01/25/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- Bank of America reports Q4 EPS 85c, consensus 77c
- 01/12/23
- Notable companies reporting before tomorrow's open
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/17/22
- Bank of America reports Q3 EPS 81c, consensus 77c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 02/06/23
- Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51
- 02/06/23
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
AMPX Amprius Technologies - 03/23/23
- Amprius Technologies reports Q4 EPS (7c), consensus (6c)
- 02/23/23
- Farfetch sees FY23 adjusted EBITDA margin 1%-3%
- 02/23/23
- Farfetch reports Q4 adjusted EPS (25c), consensus (47c)
- 02/23/23
- Notable companies reporting after market close
- 11/17/22
- Farfetch reports Q3 adjusted EPS (24c), consensus (28c)
IMPL Impel Pharmaceuticals - 08:19 Today
- Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11)
- 11/14/22
- Impel Pharmaceuticals reports Q3 EPS ($1.31), consensus ($1.00)
- 07:47 Today
- Stifel Financial sees Q1 investment banking revenue down 5%-10% from Q4
- 01/25/23
- Stifel Financial reports Q4 adjusted EPS $1.58, consensus $1.64
- 10/26/22
- Stifel Financial reports Q3 adjusted EPS $1.29, consensus $1.45
- 07:04 Today
- Oncorus reports Q4 EPS (81c), consensus (76c)
- 11/02/22
- Oncorus reports Q3 EPS (76c), consensus (75c)
- 07:02 Today
- Leap Therapeutics reports Q4 EPS (11c), consensus (11c)
- 11/14/22
- Leap Therapeutics reports Q3 EPS (13c), consensus (12c)
- 07:02 Today
- Humacyte reports Q4 EPS (4c), consensus (23c)
- 11/10/22
- Humacyte reports Q3 EPS (25c), consensus (21c)
|
